A more sensitive liver needs less GH to produce enough IGF-1
In a large trial, semaglutide 2.4 mg led to about 14.9% mean body-weight loss at 68 weeks versus 2.4% with placebo
During the first couple of weeks, some patients report: Better sleep quality More restful nights Improved recovery Mild changes in appetite As treatment continues, patients may begin to notice: Increased energy Better workout recovery Less soreness A greater sense of overall wellness This is often when more noticeable changes may begin to appear, including: Improved muscle tone Better body composition Support with fat loss Enhanced recovery after exercise With consistency, many patients experience: Continued support for lean muscle development More noticeable body composition changes Ongoing recovery benefits Improved overall results when combined with a healthy lifestyle Why Choose Intra-V

Available in 2 stacks save up to 120,00 Lean Mass - Startsave 40,00 View the stack Lean Mass - Advancedsave 120,00 View the stack IGF-1 LR3 - Advanced Anabolic Signaling & Muscle Growth Activates anabolic IGF pathways Longer half-life than native IGF-1 Engages mTOR-related signaling Studied in tissue repair models Direct IGF receptor stimulation Influences proliferation pathways Increased bioavailability profile Supports muscle precursor cell signaling Description IGF-1 LR3 is a modified analog of insulin-like growth factor 1 engineered with an extended amino acid sequence and reduced affinity for IGF-binding proteins
Because it influences the same pathway as ghrelin, the hunger hormone, appetite may increase in some people
Combine the two and you have one compound filling the tank and easing off the brake while the other opens the valve